西酞普兰联合中药治疗对于抑郁症的HAMD、 HAMA、 MADS评分及安全性研究

Influence on the scores of HAMD, HAMA, MADS and safety for the patients with depression by citalopram combine with chinese traditional medicine

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2018, 45(1)
作者
作者单位

新乡医学院第二附属医院 ;

摘要
探讨西酞普兰联合中药治疗对于抑郁症的HAMD、 HAMA、 MADS评分及安全性等影响。方法 将2013/01至2015/12来我院接受治疗的78例抑郁症患者纳入本研究。按照入院顺序抽签后随机分为实验组和对照组,实验组:西酞普兰联合中药治疗。对照组:西酞普兰治疗。观察患者临床疗效、汉密尔顿抑郁量表(HAMD)、Hamilton焦虑量表(HAMA)、Montgomery-Asber9抑郁量表(MADS)评分、血清皮质醇、PFP-5-HT、NE水平以及安全性。结果 实验组治疗总有效率为89.74%,高于对照组的69.23%,有统计学差异(P<0.05);实验组治疗后HAMD、HAMA、MADS评分低于治疗前和对照组,有统计学差异(P<0.05);对照组治疗后HAMD、HAMA、MADS评分低于治疗前,有统计学差异(P<0.05)。实验组治疗后血清皮质醇、NE水平低于治疗前和对照组,有统计学差异(P<0.05);对照组治疗后血清皮质醇、NE水平低于治疗前,有统计学差异(P<0.05)。实验组治疗前后PFP-5-HT水平对比,差异无统计学意义(P>0.05);实验组治疗后PFP-5-HT水平低于对照组,有统计学差异(P<0.05);对照组治疗后PFP水平高于治疗前,有统计学差异(P<0.05)。实验组不良反应总发生率为28.21%,低于对照组的51.28%,有统计学差异(P<0.05)。结论西酞普兰联合中药治疗抑郁症,效果较好,患者HAMD、 HAMA、 MADS评分较低,血清皮质醇、PFP-5-HT、NE水平控制较好,安全性较好,临床应用价值较高。
Abstract
Objective To explore the influence on the scores of HAMD, HAMA, MADS and safety for the patients with depression by citalopram combine with chinese traditional medicine. Methods 78 cases of patients with depression were randomly divided into experiment group and control group, the experiment group were treated by citalopram combine with chinese traditional medicine, the control group were treated by citalopram. The clinical effects, the scores of HAMD, HAMA, MADS, the levels of serum cortisol, PFP, NE, the safety were observed. Results The total effective rate for the experiment group(89.74%) were higher than the control group(69.23%)(P<0.05); The scores of HAMD, HAMA, MADS for the experiment group after treatment were lower than before treatment and the control group(P<0.05); The scores of HAMD, HAMA, MADS for the control group after treatment were lower than before treatment(P<0.05); The levels of serum cortisol, NE for the experiment group after treatment were lower than before treatment and the control group(P<0.05); The levels of serum cortisol, NE for the control group after treatment were lower than before treatment(P<0.05); There had no significant difference on the levels of PFP-5-HT before and after treatment(P>0.05); The levels of PFP-5-HT for the experiment group after treatment were lower than the control group(P<0.05); The levels of PFP-5-HT for the control group after treatment were higher than before treatment(P<0.05); The adverse reactions for the experiment group(28.21%) were lower than the control group(51.28%)(P<0.05). Conclusion It has good clinical effects for the patients with depression by citalopram combine with chinese traditional medicine, it has low scores of HAMD, HAMA, MADS, with good levels of serum cortisol, PFP, NE, good safety, it has high values of clinical application.
关键词
西酞普兰;中药;血清皮质醇;PFP-5-HT
KeyWord
Citalopram; Traditional chinese medicine; serum cortisol; PFP
基金项目
页码 72-74
  • 参考文献
  • 相关文献
  • 引用本文

杜明君*,肖伟霞,申丽娟,蒋燕升. 西酞普兰联合中药治疗对于抑郁症的HAMD、 HAMA、 MADS评分及安全性研究 [J]. 国际精神病学杂志. 2018; 45; (1). 72 - 74.

  • 文献评论

相关学者

相关机构